226 related articles for article (PubMed ID: 25236716)
1. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis.
Zhang B; Zhu F; Ma X; Tian Y; Cao D; Luo S; Xuan Y; Liu L; Wei Y
Radiother Oncol; 2014 Aug; 112(2):250-5. PubMed ID: 25236716
[TBL] [Abstract][Full Text] [Related]
2. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
[TBL] [Abstract][Full Text] [Related]
3. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
[TBL] [Abstract][Full Text] [Related]
4. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.
Viani GA; Gouveia AG; Yan M; Matsuura FK; Moraes FY
J Bras Pneumol; 2022; 48(3):e20210390. PubMed ID: 35508065
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiotherapy Versus Surgery for Early-Stage Non-Small-Cell Lung Cancer.
Li H; Shen Y; Wu Y; Cai S; Zhu Y; Chen S; Chen X; Chen Q
J Surg Res; 2019 Nov; 243():346-353. PubMed ID: 31277011
[TBL] [Abstract][Full Text] [Related]
7. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
[TBL] [Abstract][Full Text] [Related]
8. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis.
Zheng X; Schipper M; Kidwell K; Lin J; Reddy R; Ren Y; Chang A; Lv F; Orringer M; Spring Kong FM
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):603-11. PubMed ID: 25052562
[TBL] [Abstract][Full Text] [Related]
9. Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
Raghavan G; Shaverdian N; Chan S; Chu FI; Lee P
Clin Lung Cancer; 2018 Sep; 19(5):e759-e766. PubMed ID: 29954680
[TBL] [Abstract][Full Text] [Related]
10. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.
Palma D; Lagerwaard F; Rodrigues G; Haasbeek C; Senan S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1149-56. PubMed ID: 21640513
[TBL] [Abstract][Full Text] [Related]
11. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
Rosen JE; Salazar MC; Wang Z; Yu JB; Decker RH; Kim AW; Detterbeck FC; Boffa DJ
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):44-54.e9. PubMed ID: 27131846
[TBL] [Abstract][Full Text] [Related]
12. Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis.
Zhang J; Yang F; Li B; Li H; Liu J; Huang W; Wang D; Yi Y; Wang J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e305-16. PubMed ID: 21658853
[TBL] [Abstract][Full Text] [Related]
13. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.
Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman B; Senan S
Radiother Oncol; 2011 Nov; 101(2):240-4. PubMed ID: 21775007
[TBL] [Abstract][Full Text] [Related]
14. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence?
Guckenberger M
Expert Rev Anticancer Ther; 2015 May; 15(5):525-30. PubMed ID: 25761997
[TBL] [Abstract][Full Text] [Related]
16. Retrospective comparison between definitive stereotactic body radiotherapy and radical surgery for 538 patients with early-stage non-small cell lung cancer in a single institution.
Miki Y; Yamashita H; Nakajima J; Karasaki T; Kitano K; Katano A; Takenaka R; Ogita M; Sawayanagi S; Minamitani M; Jinnouchi H; Noyama T; Takeuchi K; Ishida A; Abe O
J Cancer Res Ther; 2023; 19(5):1350-1355. PubMed ID: 37787307
[TBL] [Abstract][Full Text] [Related]
17. Prognositc significance of SUV
Dong M; Liu J; Sun X; Xing L
J Med Imaging Radiat Oncol; 2017 Oct; 61(5):652-659. PubMed ID: 28266166
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer.
Li C; Wang L; Wu Q; Zhao J; Yi F; Xu J; Wei Y; Zhang W
Medicine (Baltimore); 2020 Aug; 99(34):e21715. PubMed ID: 32846789
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
